Dayton Heart Center

Dayton, Ohio 45414

0 studies enrolling now · 8 studies all time

What they study most

Atrial Fibrillation, Cardio-pulmonary Bypass, Cardiovascular Disease, Congestive Heart Failure, Coronary Artery Bypass Graft, Heart Failure, Hyperlipidemia, Peripheral Arterial Disease

Studies at this site

• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Pantheris Atherectomy Treatment of In-Stent Restenosis In Lower Extremity Arteries — Completed
• Cardiovascular Inflammation Reduction Trial — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins — Completed
• Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass — Completed
• Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management — Completed
• Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure — Completed